You know the old saying, wait ages for a bus and then two come along at once. This time it’s not a double decker lumbering ...

particularly Amyotrophic Lateral Sclerosis (ALS), also known as motor neurone disease (MND). The company is advancing its lead asset, monepantel, a repurposed drug originally developed as a ...

Several ASX companies are conducting clinical trials, and this has become a valuable sector and an asset to the Australian ...

Australia has a hard-earned global reputation as a ‘go to’ destination to conduct clinical trials, which is continuing to ...

Stock of Applied Therapeutics, Inc. surges as FDA skips AdCom for AT-007 in galactosemia. Read more on recent developments ...

September 10, marked World Suicide prevention day. Looking ahead, October 10, is World Mental Health Day. This year’s theme ...

while patients also exhibit non-motor manifestations, such as cognitive decline, mood disturbances, and sleep disorders. While the exact cause of the dopaminergic neuron loss is not fully understood, ...

A year later, the FDA expanded Elevidys's label to include DMD patients aged four and older ... SMA is a rare genetic disorder that affects motor neuron function, leading to severe muscle weakness and ...

Motor neuron diseases are a group of progressive and ultimately fatal neurodegenerative disorders of the motor system, ...

Drugs that "switch on" vitamin A in the body may also help stave off conditions such as motor neuron disease (MND).